Drug Database
Back to search

Poland· PL-100009713

Berotec N 100

A fenoterol product containing fenoteroli hydrobromidum, registered in Poland by Boehringer Ingelheim International GmbH. The same ATC class is registered in 3 of our 19 countries.

ATC R03AC04

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedBerotec N 100ATCR03AC04REGISTER NO.PL-100009713PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fenoteroli hydrobromidumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Fenoterol is registered in 3 of 19 countries.

Countries holding a registration under ATC R03AC04 (fenoterol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 3 of them publish a price we can compare per daily dose
Search fenoterol products by name

Fenoterol · ATC R03AC04

3 / 19 countries

  • Finlandprice
  • Norwayprice
  • Polandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Fenoteroli hydrobromidum
Manufacturer
Boehringer Ingelheim International GmbH
Country
Poland (PL)
ATC code
R03AC04
ATC class
Fenoterol
Defined daily dose
0.6 mg, Inhal
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

1 priced
  • gtin
    05909990376414
    1 poj.po 10 ml (200 daw.)
    PLN 24.1

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fenoterol in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fenoterol products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Germany · Berotec N Dosier-Aerosol, Partusisten
  • Estonia · Berotec N
  • Lithuania · Berotec N

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/79f3d76b-5680-44d1-a661-4d855bb0c442
GET /v1/drugs/79f3d76b-5680-44d1-a661-4d855bb0c442?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Aerozol inhalacyjny, roztwór",
  "source": "urpl",
  "strength": "100 mcg/dawkę inh.",
  "packaging": "05909990376414 ¦ Rp ¦ 1831\n1 poj. 10 ml (200 dawek)",
  "substance": "Fenoteroli hydrobromidum 100 mcg",
  "common_name": "Fenoteroli hydrobromidum",
  "pl_product_id": "100009713",
  "pozwolenie_nr": "03764",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about fenoterol.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console